Precision Biosciences (DTIL) Research & Development (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Research & Development data on file, last reported at $13.1 million in Q1 2026.

• Research & Development for Q1 2026 came in at $13.1 million, down 3.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.7 million (down 10.22% YoY), and the FY2025 annual result was $54.2 million, down 9.04% from the prior year.
• Research & Development eased to $13.1 million in Q1 2026 per DTIL's latest filing, from $14.5 million in the prior quarter.
• Over five years, Research & Development peaked at $22.9 million in Q2 2022 and troughed at $11.0 million in Q1 2023.
• A 5-year average of $14.6 million and a median of $13.4 million in 2025 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2023: Research & Development sank 54.67% in 2022, then jumped 34.8% in 2023.
• A 5-year view of Research & Development shows it stood at $12.7 million in 2022, then increased by 5.57% to $13.4 million in 2023, then increased by 18.81% to $15.9 million in 2024, then fell by 9.07% to $14.5 million in 2025, then fell by 9.36% to $13.1 million in 2026.
• Business Quant data shows DTIL's Research & Development at $13.1 million in Q1 2026, $14.5 million in Q4 2025, and $13.4 million in Q3 2025.